Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery

Head Neck. 2023 Jan;45(1):126-134. doi: 10.1002/hed.27218. Epub 2022 Oct 12.

Abstract

Background: The immune profile in primary resected hypopharyngeal squamous cell carcinoma (HPSCC) and its prognostic value remain to be defined.

Methods: We enrolled 100 patients with HPSCC underwent primary surgical resection at our department. HPSCC samples were examined using immunohistochemistry for the expressions of CD8, Foxp3, CD163, CD66B, programmed death ligand-1 (PD-L1), and interferon (IFN)-γ. The immune pattern of the tumor microenvironment (TME) was discriminated into inflamed and non-inflamed tumors based on the presence or absence of parenchymal CD8+ T cells.

Results: We found that 74% of HPSCC cases in our cohort were characterized by an immune-inflamed TME. Immune-inflamed patterns demonstrated an inferior survival with a significantly increased density of CD163+ tumor-associated macrophages and Foxp3+ regulatory T cells. Additionally, the inflamed tumor showed increased expression of PD-L1, without IFN-γ upregulation.

Conclusions: The immune-inflamed pattern is the predominant preexisting immune phenotype in HPSCC and demonstrates immunosuppressive immune cell recruitment.

Keywords: Hypopharyngeal carcinoma; Immunoscore; programmed death ligand-1; squamous cell carcinoma; tumor immune microenvironment.

MeSH terms

  • B7-H1 Antigen / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Carcinoma* / pathology
  • Humans
  • Hypopharyngeal Neoplasms* / pathology
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Prognosis
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen